There is a shortage of coronavirus vaccines in the world. The German company BioNTech is looking for opportunities to increase production to vaccinate as many people and countries as possible.
This was announced by the CEO and co-founder of BioNTech Ugur Shahin in an interview with Spiegel.
вЂњWe are trying to get new partners who will manufacture (the drug) for us. However, itвЂ™s not so simple вЂ” as if specialized factories are standing and not being used all over the world, which tomorrow will be able to produce a vaccine of the required quality,вЂќ Shahin said.
According to him, it will only be clear at the end of January whether the company will be able to produce additional doses of the COVID-19 vaccine.
Shahin drew attention to the fact that the situation with the production of the required amount of vaccine is catastrophic. Many manufacturers have not yet received permission, and the population is in need of vaccination.